TLT.V
Theralase Technologies Inc.
TSXV
People also watch:ZMS.VSBM.VPHM.VKEK.VCXV.V
0.430.02 (4.88%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.41
Open0.41
Bid0.43 x
Ask0.43 x
52wk Range0.25 - 0.45
Day's Range0.41 - 0.44
Volume227,291
Avg Vol (3m)134,390
As of 3:59 PM EDT. Market closed.
  • Zacks Small Cap Research2 months ago

    TLT.V: Q1 2016 Financial Results; Revenue Misses Estimates But Growth Is Stronger Than Q1 2015

    Revenue came in at ~$400,000 but widely missed our estimate by ~50%.  The domestic market (Canada) revenue decreased ~50% as compared to the same period in 2015 offsetting more than ~50% bump in international regions.  The U.S. revenue jumped by 1700% from Q1 2015.  Theralase is focused on training its marketing team to grow its U.S. revenues as well as international revenues through exclusive distribution agreements.

  • Theralase Technologies, Inc. Earnings Q2, 2015
    Capital Cube11 months ago

    Theralase Technologies, Inc. Earnings Q2, 2015

    Theralase Technologies, Inc. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of Theralase Technologies Inc. – Pyng Medical Corp., Verisante Technology, Inc., Medx Health Corp. and CRH Medical Corporation (PYT-CA, VRS-CA, MDX-CA and CRH-CA) that have also reported for this period.HighlightsSummary numbers: Revenues of […] (Read more...) The post Theralase Technologies, Inc. Earnings Q2, 2015 appeared first on CapitalCube.